258 related articles for article (PubMed ID: 14521410)
41. Comparison of ketoconazole and fluconazole as cytochrome P450 inhibitors. Use of steady-state infusion approach to achieve plasma concentration-response relationships.
Ervine CM; Matthew DE; Brennan B; Houston JB
Drug Metab Dispos; 1996 Feb; 24(2):211-5. PubMed ID: 8742233
[TBL] [Abstract][Full Text] [Related]
42. Pyrrole alkanoic acid derivatives as nuisance inhibitors of microsomal prostaglandin E2 synthase-1.
Wiegard A; Hanekamp W; Griessbach K; Fabian J; Lehr M
Eur J Med Chem; 2012 Feb; 48():153-63. PubMed ID: 22209272
[TBL] [Abstract][Full Text] [Related]
43. 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
La Regina G; D'Auria FD; Tafi A; Piscitelli F; Olla S; Caporuscio F; Nencioni L; Cirilli R; La Torre F; De Melo NR; Kelly SL; Lamb DC; Artico M; Botta M; Palamara AT; Silvestri R
J Med Chem; 2008 Jul; 51(13):3841-55. PubMed ID: 18529046
[TBL] [Abstract][Full Text] [Related]
44. Chlorination-induced enhancement of biological activities in imidazole antimycotics. A possible explanation to the molecular mechanism for their antimycotic activities.
Kawai K; Shiojiri H; Watanabe R; Nozawa Y
Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):255-65. PubMed ID: 6878866
[TBL] [Abstract][Full Text] [Related]
45. Interpreting steep dose-response curves in early inhibitor discovery.
Shoichet BK
J Med Chem; 2006 Dec; 49(25):7274-7. PubMed ID: 17149857
[TBL] [Abstract][Full Text] [Related]
46. Anti-Candida activity and cytotoxicity of a large library of new N-substituted-1,3-thiazolidin-4-one derivatives.
De Monte C; Carradori S; Bizzarri B; Bolasco A; Caprara F; Mollica A; Rivanera D; Mari E; Zicari A; Akdemir A; Secci D
Eur J Med Chem; 2016 Jan; 107():82-96. PubMed ID: 26562544
[TBL] [Abstract][Full Text] [Related]
47. Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.
Mai A; Rotili D; Massa S; Brosch G; Simonetti G; Passariello C; Palamara AT
Bioorg Med Chem Lett; 2007 Mar; 17(5):1221-5. PubMed ID: 17196388
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Draper AJ; Madan A; Parkinson A
Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
[TBL] [Abstract][Full Text] [Related]
49. QSAR model for predicting the fungicidal action of 1,2,4-triazole derivatives against Candida albicans.
Singla RK; Bhat G V
J Enzyme Inhib Med Chem; 2010 Oct; 25(5):696-701. PubMed ID: 20429780
[TBL] [Abstract][Full Text] [Related]
50. Activity profile relationships between structurally similar promiscuous compounds.
Hu Y; Bajorath J
Eur J Med Chem; 2013 Nov; 69():393-8. PubMed ID: 24077530
[TBL] [Abstract][Full Text] [Related]
51. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
52. [Action of ultrasonics on alpha-chymotrypsin. A new approach to the study of conformational changes (transitions) in the active centers of enzymes].
Klibanov AM; Martinek K; Berezin IV
Biokhimiia; 1974; 39(4):878-87. PubMed ID: 4441574
[No Abstract] [Full Text] [Related]
53. Inhibition of human alcohol dehydrogenases by formamides.
Schindler JF; Berst KB; Plapp BV
J Med Chem; 1998 May; 41(10):1696-701. PubMed ID: 9572895
[TBL] [Abstract][Full Text] [Related]
54. Screening of antimycotics in Swedish sewage treatment plants--waters and sludge.
Lindberg RH; Fick J; Tysklind M
Water Res; 2010 Jan; 44(2):649-57. PubMed ID: 19942249
[TBL] [Abstract][Full Text] [Related]
55. Fungal phenalenones inhibit HIV-1 integrase.
Shiomi K; Matsui R; Isozaki M; Chiba H; Sugai T; Yamaguchi Y; Masuma R; Tomoda H; Chiba T; Yan H; Kitamura Y; Sugiura W; Omura S; Tanaka H
J Antibiot (Tokyo); 2005 Jan; 58(1):65-8. PubMed ID: 15813183
[TBL] [Abstract][Full Text] [Related]
56. Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity.
Borate HB; Sawargave SP; Chavan SP; Chandavarkar MA; Iyer R; Tawte A; Rao D; Deore JV; Kudale AS; Mahajan PS; Kangire GS
Bioorg Med Chem Lett; 2011 Aug; 21(16):4873-8. PubMed ID: 21757344
[TBL] [Abstract][Full Text] [Related]
57. Distribution, behavior and fate of azole antifungals during mechanical, biological, and chemical treatments in sewage treatment plants in China.
Peng X; Huang Q; Zhang K; Yu Y; Wang Z; Wang C
Sci Total Environ; 2012 Jun; 426():311-7. PubMed ID: 22521100
[TBL] [Abstract][Full Text] [Related]
58. Catalytic and binding poly-reactivities shared by two unrelated proteins: The potential role of promiscuity in enzyme evolution.
James LC; Tawfik DS
Protein Sci; 2001 Dec; 10(12):2600-7. PubMed ID: 11714928
[TBL] [Abstract][Full Text] [Related]
59. Reduction of Promiscuous Peptides-Enzyme Inhibition and Aggregation by Negatively Charged Biopolymers.
Fu J; Nguyen K
ACS Appl Bio Mater; 2022 May; 5(5):1839-1845. PubMed ID: 34995072
[TBL] [Abstract][Full Text] [Related]
60. A Method for Identifying Small-Molecule Aggregators Using Photonic Crystal Biosensor Microplates.
Chan LL; Lidstone EA; Finch KE; Heeres JT; Hergenrother PJ; Cunningham BT
JALA Charlottesv Va; 2009 Dec; 14(6):348-359. PubMed ID: 20930952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
